GL1X · GenesisL1 explorer

MolNFT v1 · #17787 · protein

Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data

1P45 · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural…”. X-ray diffraction, 2 ligands (TCL, NAD), 8 pockets (best druggability…

PDB
1P45
Type
protein
Length
536 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P0A5Y6
Ligands
TCL, NAD
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26844% helix, 16% strandP0A5Y6

Ligands and binding sites

  • TCL · Triclosan · ligand · 3 copies · chains A, B
  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15770.810.8648NAD, TCL
27750.800.8354NAD, TCL
31330.430.7617empty
41130.390.7615empty
5790.380.7716empty

Interfaces

1 interface between chains.

  • A–B · 1579 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 1P45 · Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.